StonvexLoading…
StonvexStonvexStonvexCore line items from OPAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $326.72M | $290.86M | $251.15M | $230.66M |
Operating Income | $7.41M | $21.22M | $7.04M | $7.56M |
Net Income | $36.41M | $14.32M | $127.02M | $32.58M |
EPS (Diluted) | $0.15 | $0.02 | $0.69 | $0.12 |
Total Assets | $959.47M | $881.08M | $754.61M | $644.86M |
Total Liabilities | $461.71M | $416.05M | $297.12M | $267.04M |
Cash & Equivalents | $24.41M | $24.31M | $38.35M | $40.39M |
Free Cash Flow OCF − CapEx | $-34.24M | $-95.85M | $-75.56M | $-132.76M |
Shares Outstanding | 29.25M | 27.69M | 27.49M | 26.06M |